Article Details
Retrieved on: 2025-01-31 18:20:56
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses CHMP's recommendation to extend Ronapreve's marketing authorization, a COVID-19 monoclonal antibody treatment by Roche, to include younger children, enhancing its role in COVID management. Tags and concept align on drug development and regulatory aspects.
Article found on: www.ema.europa.eu
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here